middle.news
Proteomics International Secures US Patent for PromarkerEndo Diagnostic Test
10:09am on Wednesday 8th of July, 2026 AEST
•
Healthcare
Read Story
Proteomics International Secures US Patent for PromarkerEndo Diagnostic Test
10:09am on Wednesday 8th of July, 2026 AEST
Key Points
US patent granted for PromarkerEndo diagnostic test
Patent protection extends to 2041 in the US
PromarkerEndo targets early-stage endometriosis diagnosis
Patent strengthens commercialisation and licensing prospects
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE